ARCHIVES

Conte To Introduce Bill To Stem Loss Of NIH “Superstars”

This article is from The Cancer Letter archive.

Vol. 15 No. 13 | March 31, 1989

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

NCI R01 Payline Stays At 12th Percentile for FY07.

February 9, 2007

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

April 16, 2004

NIH Revises Application Receipt Dates

November 22, 1985

Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder

October 20, 1995